ZENSUN ENT (00185.HK) announced its interim results for the period ending June this year, with a revenue of RMB 2.624 billion, an increase of 1326.8% year-on-year. The loss narrowed to RMB 502 million, compared to a loss of RMB 1.597 billion in the same period last year; the loss per share was 26.2 cents. No dividend was declared